Scopolamine bioavailability in combined oral and transdermal delivery.
about
Antidepressant effects of the muscarinic cholinergic receptor antagonist scopolamine: a reviewTransdermal delivery of scopolamine by natural submicron injectors: in-vivo study in pigMechanisms underlying rapid experience-dependent plasticity in the human visual cortex.The muscarinic antagonists scopolamine and atropine are competitive antagonists at 5-HT3 receptors.Motion sickness: more than nausea and vomiting
P2860
Scopolamine bioavailability in combined oral and transdermal delivery.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Scopolamine bioavailability in combined oral and transdermal delivery.
@ast
Scopolamine bioavailability in combined oral and transdermal delivery.
@en
type
label
Scopolamine bioavailability in combined oral and transdermal delivery.
@ast
Scopolamine bioavailability in combined oral and transdermal delivery.
@en
prefLabel
Scopolamine bioavailability in combined oral and transdermal delivery.
@ast
Scopolamine bioavailability in combined oral and transdermal delivery.
@en
P2093
P1476
Scopolamine bioavailability in combined oral and transdermal delivery
@en
P2093
P304
P407
P577
2001-01-01T00:00:00Z